Nebula Biotechnology Co., Ltd..

+86-15801534258
info@nebulabio.cn
Product Name NebuSelect™ Recombinant Human ALK-1/Activin RL1, His-tag
Catalog Number NBL-243117
Alias/Synonyms ALK-1/Activin RL1; ACVRLK1; ORW2; ALK1; ALK-1; EC 2.7.11; HHT; HHT2; SKR3; TSR-I; ACVRL1
Appearance see COA
Molecule Weight
CAS N/A
Solubility Water Soluble
Storage Short term 4℃; Long term -20℃.
Shelf Life 2 years
Additional info 1 P37023
Additional info 2
Catalog Numbe Size Price Inventory Level  
NBL-243117-100ug 100ug Inquire Inquire
NBL-243117-1mg 1mg Inquire Inquire
NBL-243117-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human ALK-1/Activin RL1, His-tag


Catalog#:

NBL-243117


Description:

NebuSelect™ Recombinant Human ALK-1/Activin RL1, His-tag(Cat#NBL-243117) is expressed in HEK293 with His tag at the C-Terminus.It contains Asp22-Gln118.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 11.5 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result.


Target Name:

ALK-1/Activin RL1; ACVRLK1; ORW2; ALK1; ALK-1; EC 2.7.11; HHT; HHT2; SKR3; TSR-I; ACVRL1


Target Information:

Activin receptor-like kinase 1 (ALK1)-mediated endothelial cell signalling in response to bone morphogenetic protein 9 (BMP9) and BMP10 is of significant importance in cardiovascular disease and cancer. Structural analyses reveal a tripartite recognition mechanism that defines BMP9 and BMP10 specificity for ALK1, and predict that crossveinless 2 is not an inhibitor of BMP9, which is confirmed by experimental evidence.


Amino Acid Sequence: 


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

Top-selling Items